Business
Pluri CEO Issues Shareholder Letter Highlighting Strategic Growth, Innovation, and Global Market Expansion
Major milestones include entry into cultivated cacao and coffee markets and progress toward commercial-scale productionCompany reports nearly 400% revenue growth in the first nine months of fiscal year 2025 compared to the same period in fiscal year 2024, driven by its CDMO and AgTech businesses, and is advancing new food tech partnerships and licensing opportunities HAIFA, Israel, May 15, 2025 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq, TASE: PLUR) (“Pluri” or the “Company”), a leading biotechnolog
About this update from Pluri Inc.
[{"type":"image","alt":"Pluri Inc.","displaySize":"","headline":null,"caption":"Pluri Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":120,"height":70,"url":"https://media.zenfs.com/en/globenewswire.com/d5a4051630c54382ed0eee086a38698c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/1tW4todUQDjndMreKHMwkQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTEyMztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/d5a4051630c54382ed0eee086a38698c","width":120,"height":70}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Major milestones include entry into cultivated cacao and coffee markets and progress toward commercial-scale production","length":119,"tagName":"p"}]},{"val":[{"type":"text","content":"Company reports nearly 400% revenue growth in the first nine months of fiscal year 2025 compared to the same period in fiscal year 2024, driven by its CDMO and AgTech businesses, and is advancing new food tech partnerships and licensing opportunities","length":250,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":369,"olType":false},{"type":"text","content":"HAIFA, Israel, May 15, 2025 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq, TASE: PLUR) (“Pluri” or the “Company”), a leading biotechnology company leveraging its proprietary platform for cell-based solutions to create a collaborative network of ventures, today issued the following shareholder update from Chief Executive Officer and President, Yaky Yanay:","length":349,"tagName":"p"},{"type":"text","content":"Dear Shareholders,","length":18,"tagName":"p"},{"type":"text","content":"As we conclude our fiscal year, which was marked by challenges and accomplishments, I’m pleased to share key developments and to outline our path forward. Pluri is aiming to lead a global biotech revolution in the fields of healthcare, food, and agriculture by leveraging our innovative cell expansion platform. This platform enables us to grow cells from diverse sources and transform them into pharmaceuticals, food products, and agricultural goods to address many multi-billion dollar markets.","length":496,"tagName":"p"},{"type":"text","content":"We anticipate that the coming fiscal year will mark a significant turning point, as we unlock the potential of our cell expansion technology to deliver scalable global solutions — particularly in the cocoa and coffee industries, where clima...